Clinical trials have consistently demonstrated that these medications can help patients achieve significant and sustained weight loss, often 10-15% of body weight
Gallwitz B (2011) Glucagon-like peptide-1 analogues for type 2 diabetes mellitus: current and emerging agents
Semaglutide (self-pay offers via NovoCare Pharmacy) Ozempic (weekly injection): $199/month for the first 2 fills at 0.25 mg or 0.5 mg, Then $349/month for 0.25/0.5/1 mg
or collapse (possible anaphylaxis) Severe abdominal pain (possible pancreatitis) Signs of infection at the injection site (redness, swelling, discharge, or fever) Persistent vomiting or inability to tolerate fluids Chest pain, palpitations, or difficulty breathing Severe dizziness or loss of consciousness For non-urgent concerns, contact your GP or call NHS 111 for advice
PlexusDx recommends baseline and periodic monitoring of pancreatic function in higher-risk patients